In a similar set-up (Fig. 4f) the immune stimulatory effect of ATOR-1017 was demonstrated to be tumor-directed resulting in an increased ratio of CD8 + T cells vs Tregs in the tumor (Fig. 4g) but not in the periphery (in the spleen, Fig. 4h). Here, CD8A is linked to neoplasm.